Sorry, you need to enable JavaScript to visit this website.
PATIENT ENGAGEMENT

Patient organization

Cooperation with patient organizations

The patient comes first

For Bayer, one of the world's leading specialty pharmaceutical companies, patients' health always comes first. Exchanging ideas and information with patient organizations on the basis of mutual trust is an important component of our work.

Such cooperation helps us to understand the needs of patients as they come to terms with their illness. This enables us to gear our research and development to these needs and to continue working on improved, new drugs and therapies.

Bayer cooperates with patient organizations in all kinds of therapeutic areas. We attach great importance to transparency in this context and protect the independence of our cooperation partners.

 

Our principles

Cooperation between Bayer and patient organizations is based on the following principles.

  1. In order to provide patients with quality medical healthcare, a partnership with a patient organization pursues a specific objective concentrating on one or more of the following areas:
    • raising awareness for certain diseases by improving diagnostic possibilities and preventive measures, knowing the patients' prospects and needs,
    • understanding diseases and making sure that patients receive the best medical treatment available,
    • improving the information provided to the patients,
    • supporting medical innovations.
  2. Bayer and the patient organizations comply with international and national laws and regulations.
  3. Cooperation with a patient organization should neither influence decisions on a therapy nor promote or support specific therapies.
  4. Bayer respects the neutrality and independence of patient organizations. Cooperation is based on a partnership between equals in which transparency and clarity are fundamental principles. This is why we also provide information on the extent and nature of support.

Overview of cooperation with patient organizations in Europe in 2019

The following is a list of patient organizations with which Bayer and its affiliated companies in Europe cooperated in 2019.

 

Headquarters:

Bayer Company Bayer AG
Contract date 01.11.2019
Amount 90.000 EUR
Purpose of interaction Sponsorship of annual patient representative meeting 

 

Bayer Company Bayer AG
Contract date 01.06.2019
Amount 25.000 EUR
Purpose of interaction Sponsorship of World Scleroderma Day

 

Bayer Company Bayer AG
Contract date 01.02.2019
Amount 5.000 EUR
Purpose of interaction Membership fee for EURORDIS

 

Bayer Company Bayer AG
Contract date 05.07.2019
Amount 120.000 EUR
Purpose of interaction Support of 2 Events (Working conference in Porto in Nov 2019 & development of a concept for a European Stroke Forum)

 

Bayer Company Bayer AG
Contract date 12.02.2019
Amount 2.380 EUR
Purpose of interaction „Förderkreis-Mitgliedschaft 2019“

 

Bayer Company Bayer AG
Contract date 04.02.2019
Amount 5.000 EUR
Purpose of interaction Hotel in Toronto to attend the DR Barometer Global Advisory Committee meeting and to attend partner meetings to plan collaboration activities between the International Federation of Ageing and the IAPB

 

Bayer Company BCC AG
Contract date 28.05.2019
Amount 659,50 CHF
Purpose of interaction Hotel in Toronto to attend the DR Barometer Global Advisory Committee meeting and to attend partner meetings to plan collaboration activities between the International Federation of Ageing and the IAPB

 

Bayer Company BCC AG
Contract date 28.05.2019
Amount 8.109,95 CHF
Purpose of interaction Travel arrangements Toronto, DR Barometer SC Meeting

 

Bayer Company BCC AG
Contract date 09.04.2019
Amount 614,16 CHF
Purpose of interaction Congress Registration Paris, EURETINA to attend congress activities

 

Bayer Company BCC AG
Contract date 09.04.2019
Amount 162,92 CHF
Purpose of interaction Travel arrangements Paris, EURETINA to attend the DR Barometer Global Advisory Committee meeting and congress activities

 

Bayer Company BCC AG
Contract date 12.12.2019
Amount 20.000 USD
Purpose of interaction Sponsorship of the World Sight Day (WSD) Photo Competition, an awareness raising campaign in the lead up to WSD which is an annual day of awareness to focus global attention on blindness and vision impairment. 

 

Bayer Company BCC AG
Contract date 13.12.2019
Amount 50.000 GBP
Purpose of interaction Sponsorship of the International Agency for Prevention of Blindness, in partnership with the Singapore Eye Research Institute, 2020 Global Assembly. The Event is the quadrennial premier global event focussed on all aspects of public health issues related to blindness and visual impairment. 

 

Bayer Company Bayer AG
Contract date 13.12.2019
Amount 100.000 USD
Purpose of interaction Annual sponsorship of the International Agency for Prevention of Blindness anto undertake work in advocating for the implementation of the Universal Eye Health and the Global Action Plan, support the development, roll out and uptake of the WHO’s ‘World Report on Vision’, continued engagement of the Sustainable Development Goals and provision of membership services.

 

Bayer Company BCC AG
Contract date 09.04.2019
Amount 171,55 CHF
Purpose of interaction Travel arrangements Paris, EURETINA to attend the DR Barometer Global Advisory Committee meeting and congress activities

 

Bayer Company BCC AG
Contract date 28.05.2019
Amount 219,08 CHF
Purpose of interaction Hotel in Toronto to attend the DR Barometer Global Advisory Committee meeting

 

Bayer Company BCC AG
Contract date 28.05.2019
Amount 8.389,75 CHF
Purpose of interaction Travel arrangements Toronto to attend the DR Barometer Global Advisory Committee

 

Bayer Company BCC AG
Contract date 22.05.2019
Amount 68.500 Euro
Purpose of interaction Anunal sponsorship to support the IDF's involvement in the DR Barometer program to:                                             •    Work with partners, other experts and policymakers to support stakeholder utilisation of the Report’s findings
•    Support healthcare professionals through the provision of education on DR
•    Ensure promotion of Program activities to relevant healthcare professionals through various channels including a DR Barometer Symposium at the IDF Annual Congress

 

 

Bayer Company BCC AG
Contract date 11.01.2019
Amount 68.000 EUR
Purpose of interaction 2019 Sponsorship of Pedalea Hemophilia
Bayer Company BCC AG
Contract date 21.01.2019
Amount 37.000 EUR
Purpose of interaction EHC conference Sponsorship

 

Bayer Company BCC AG
Contract date 21.01.2019
Amount 45.000 EUR
Purpose of interaction ECH Annual Sponsorship

 

 

Europe:

Reports can be received from    

UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania) 
Alina Tikuišiene MD
Zirmunu str. 68A 
LT-09124 Vilnius/Lithunia
 

Reports can be received from    

UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania) 
Alina Tikuišiene MD
Zirmunu str. 68A 
LT-09124 Vilnius/Lithunia
 

Reports can be received from    

Bayer AB- Bayer Scandinavia
Iina Wargh
Gustav III:s Boulevard 56
169 26 Solna

Reports can be received from    

SC Bayer SRL 
Bayer Pharmaceuticals Division 
Sos. Pipera nr. 42., Sector 2 
NUSCO Tower fl. 1,16,17 
020112, Bucharest
Romania
 

Reports can be received from    

Bayer Pharma d.o.o. 
Jelena Tokanovic
Omladinskih brigada 88b
Belgrade
 

Reports can be received from    

Bayer d.o.o. 
Lucija Zlodi Gosnik
Bravnicarjeva 13
1000 Ljubljana